HKSE:01801 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HKSE:01801 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Innovent Biologics's quarterly buildings and improvements declined from Dec. 2022 (HK$702 Mil) to Jun. 2023 (HK$0 Mil) but then increased from Jun. 2023 (HK$0 Mil) to Dec. 2023 (HK$673 Mil).
Innovent Biologics's annual buildings and improvements declined from Dec. 2021 (HK$744 Mil) to Dec. 2022 (HK$702 Mil) and declined from Dec. 2022 (HK$702 Mil) to Dec. 2023 (HK$673 Mil).
The historical data trend for Innovent Biologics's Buildings And Improvements can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innovent Biologics Annual Data | |||||||||||||||||
Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Buildings And Improvements | Get a 7-Day Free Trial | 535.88 | 583.10 | 743.82 | 702.29 | 673.29 |
Innovent Biologics Semi-Annual Data | |||||||||||||||
Dec16 | Jun17 | Dec17 | Jun18 | Dec18 | Jun19 | Dec19 | Jun20 | Dec20 | Jun21 | Dec21 | Jun22 | Dec22 | Jun23 | Dec23 | |
Buildings And Improvements | Get a 7-Day Free Trial | 743.82 | - | 702.29 | - | 673.29 |
Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.
Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.
Jpmorgan Chase & Co. | 2502 Approved lending agent | |
Yu De-chao Michael | 2101 Beneficial owner | |
Temasek Holdings (private) Limited | ||
Brown Brothers Harriman & Co. | 2502 Approved lending agent | |
The Capital Group Companies, Inc. | 2201 Interest of corporation controlled by you | |
Morgan Stanley | 2201 Interest of corporation controlled by you | |
Citigroup Inc. | 2201 Interest of corporation controlled by you | |
Shi Yi | 2201 Interest of corporation controlled by you | |
Lav Asset Management (hong Kong) Limited | 2102 Investment manager | |
Eight Roads Investments | 2101 Beneficial owner | |
Fullerton Management Pte Ltd | 2201 Interest of corporation controlled by you | |
Temasek Life Sciences Private Limited | 2201 Interest of corporation controlled by you | |
Tls Beta Pte. Ltd. | 2101 Beneficial owner |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.